Related Experiment Video
Updated: Apr 22, 2026

06:04
Systematic Hearing Performance Evaluation Process for Adolescents with Cochlear Implantation at Early Ages
Published on: March 24, 2023
3.0K
A global patient outcomes registry: Cochlear paediatric implanted recipient observational study (Cochlear(™) P-IROS)
Georgina Sanderson1, Thathya V Ariyaratne1, Josephine Wyss2
1Cochlear Limited, Asia Pacific Region, Macquarie University, 1 University Avenue, Sydney, NSW 2109, Australia.
BMC Ear, Nose, and Throat Disorders
|October 16, 2014
Summary
A new international registry, Cochlear P-IROS, collects data on pediatric hearing device recipients. This will provide crucial long-term outcomes, educational, and quality of life data for implantable hearing devices.
Area of Science:
- Audiology
- Otolaryngology
- Pediatric Health Outcomes
Background:
- Limited data exists on long-term outcomes for pediatric hearing device recipients.
- A need for large, representative population samples to assess educational placement and quality of life.
Purpose of the Study:
- To establish a prospective, multinational patient-outcomes registry for pediatric recipients of implantable hearing devices.
- To collect comprehensive data on comorbidities, device use, auditory performance, and quality of life.
Main Methods:
- The Cochlear Paediatric Implanted Recipient Observational Study (Cochlear P-IROS) is a prospective, international registry.
- Utilizes a secure web interface for electronic case report forms in multiple languages.
- Data collection includes standardized questionnaires at baseline and regular follow-ups up to 24 months and annually thereafter.
Main Results:
- The registry has recruited clinics in Australia, China, India, Indonesia, Turkey, and Vietnam.
- Aims to expand recruitment to additional countries including Japan, Russia, and South Africa.
- The registry is designed to be investigator-driven and voluntary.
Conclusions:
- The Cochlear P-IROS registry will generate valuable data for researchers, clinicians, and global stakeholders.
- Data will inform the acceptance and adoption of implantable hearing devices for hearing loss treatment.
- Findings will benefit regulators, payers, providers, policymakers, and patient families.

